Skip to content

The AMD Experts

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to turn their practice into an AMD Center of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Article: July 16, 2021 | Women in Optometry

On Our Way To Better Days

How can we make timely referrals the norm, not the exception? Jessica Haynes, OD, shares how technology takes the guesswork out of monitoring and managing AMD suspects.

Our Blog: July 15, 2021

If Hindsight is 20/20, Foresight is Making a Difference

Dr. Lou shares how he needed to rethink AMD, and is proud to report that this allowed him to make a marked difference in disease management.

Article: June 30, 2021 | Review of Optometric Business

AMD & COVID: What Has the Pandemic’s Impact Been on Those with AMD?

Read how AMD went undetected due to delayed care because a patient feared catching COVID at the doctor’s office.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.